West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus
Go back to West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 328.18 +0.23 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $327.95 | 52 Week High | $84.33 | |||
| Open | $329.55 | 52 Week Low | $53.88 | |||
| Day High | $329.86 | P/E | 209.03 | |||
| Day Low | $324.68 | EPS | $1.57 | |||
| Volume | 439,910 | |||||
